**Core Concept:** Differentiating between recurrence of brain tumor and radiation therapy-induced necrosis is crucial for appropriate management of the patient. Magnetic Resonance Imaging (MRI) with its various contrast agents and sequences plays a vital role in this differentiation.

**Why the Correct Answer is Right:**
MRI is the preferred imaging modality to evaluate brain lesions due to its superior soft tissue contrast resolution and ability to visualize both parenchymal and leptomeningeal lesions. In the context of differentiating tumor recurrence from necrosis, T2-weighted and FLAIR sequences are particularly useful. These sequences demonstrate increased signal intensity in areas of tumor, edema, and inflammation, which can be helpful in distinguishing between these two entities. Additionally, MRI can provide information about the extent of the lesion, its margins, and its relationship to surrounding structures, which is essential for treatment planning.

**Why Each Wrong Option is Incorrect:**
A. Diffusion-weighted imaging (DWI) is a valuable tool in detecting tumor recurrence due to its sensitivity to increased cellularity and vascularity. However, DWI is not always reliable for distinguishing between tumor recurrence and necrosis.

B. Positron Emission Tomography (PET) scan may be helpful in detecting increased glucose uptake in brain lesions, but it is not specific enough to differentiate tumor recurrence from necrosis.

C. Computed Tomography (CT) scan is less sensitive than MRI for detecting brain lesions, particularly for small lesions or those near the ventricles. CT may show increased density in necrosis, but this is not specific to differentiate between tumor recurrence and necrosis.

D. Magnetic Resonance Spectroscopy (MRS) is a useful adjunct to MRI in assessing brain lesions, detecting changes in lipid, choline, and N-acetylaspartate peaks. However, the distinction between tumor recurrence and necrosis using MRS alone can be challenging.

**Core Concept:** MRI with the combination of T2-weighted, FLAIR, and DWI sequences is the best choice for differentiating tumor recurrence from necrosis.

**Why Each Wrong Option is Incorrect:**
A. While DWI is valuable for detecting increased cellularity and vascularity, it is not specific enough to differentiate tumor recurrence from necrosis.

B. PET scans are less specific and sensitive compared to MRI in differentiating tumor recurrence from necrosis.

C. CT scans are generally less sensitive than MRI for detecting small lesions or those near the ventricles.

D. MRS is a useful adjunct to MRI, but differentiation between tumor recurrence and necrosis is challenging.

**Clinical Pearl:**
MRI with T2-weighted, FLAIR, and DWI sequences are the best choice for differentiating tumor recurrence from necrosis, as they provide a comprehensive assessment of lesion characteristics, edema, and tissue integrity. These sequences can help in assessing cellularity, vascularity, and edema, which are crucial in making this distinction.